Posted 25th April 2018 by Jane Williams
The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips.
Posted 9th April 2018 by Jane Williams
The University of Hertfordshire’s Microfluidics & Microengineering Research Group produces microfluidics-enabled systems extending from concept, through design to development realisation and testing. There is a subtle balance of science and engineering involved in the research and the group is structured to enable this balance. We spoke to Loïc Coudron, a research fellow at the University of Hertfordshire, about his current research in microfluidic equipment.
Posted 5th February 2018 by Jane Williams
Andrew deMello is Professor of Biochemical Engineering in the Department of Chemistry & Applied Biosciences at ETH Zürich. We caught up with him at the 3rd Microfluidics Congress: Europe, where he gave us an insight into his current research at ETH Zürich.
Posted 1st December 2017 by Jane Williams
We were delighted to welcome Professor George Whitesides to the 2nd Microfluidics Congress: USA. If you weren’t able to make it, you can watch his presentation in full here.
Posted 22nd November 2017 by Jane Williams
Synthetic biology holds much promise. Researchers have been working toward using techniques to create new valuable products such as novel therapeutics and drugs, biorenewable fuels, and new biochemicals and biomaterials. It requires a multidisciplinary effort – it calls for biologists, chemists, engineers, software developers (STEM disciplines) to collaborate on finding ways to understand how genetic parts work together, and then combine them to produce useful applications.
Posted 18th October 2017 by Jane Williams
In this presentation, award winning Dr Alberto Escarpa speaks about groundbreaking research on graphene-based micromotors and quantum dots based micromotors.
Posted 29th September 2017 by Jane Williams
In 1869, Thomas Ashworth first observed circulating tumour cells (CTC) in the blood of a man with metastatic cancer using an optical microscope. He postulated that “cells identical with those of cancer itself being seen in the blood may tend to throw some light upon the mode of origin of multiple tumours existing in the same person”1.